Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Neurology
|
June 4, 2002
Plexiform neurofibromas in NF1: toward biologic-based therapy
R J Packer, D H Gutmann, A Rubenstein, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Differential effects of cAMP in neurons and astrocytes. Role of B-raf
L L Dugan, J S Kim, Y Zhang, et al.
JAMA
|
July 2, 1997
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
D H Gutmann, A Aylsworth, J C Carey, et al.
Oncogene
|
December 12, 1997
Interdomain binding mediates tumor growth suppression by the NF2 gene product
L Sherman, H M Xu, R T Geist, et al.
Genes & Development
|
April 24, 2001
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
H Morrison, L S Sherman, J Legg, et al.
Neurology
|
October 2, 2009
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma
J Yu, H Deshmukh, R J Gutmann, et al.
The Journal of Pathology
|
October 16, 2008
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene
C Filion, T Motoi, A B Olshen, et al.
Neurology
|
November 26, 2003
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1
D H Gutmann, C D James, M Poyhonen, et al.
Somatic Cell and Molecular Genetics
|
May 1, 1993
Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules
P E Gregory, D H Gutmann, A Mitchell, et al.
Journal of Neuropathology and Experimental Neurology
|
November 18, 2000
Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases
A Perry, D X Cai, B W Scheithauer, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Neurology
|
June 4, 2002
Plexiform neurofibromas in NF1: toward biologic-based therapy
R J Packer, D H Gutmann, A Rubenstein, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Differential effects of cAMP in neurons and astrocytes. Role of B-raf
L L Dugan, J S Kim, Y Zhang, et al.
JAMA
|
July 2, 1997
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
D H Gutmann, A Aylsworth, J C Carey, et al.
Oncogene
|
December 12, 1997
Interdomain binding mediates tumor growth suppression by the NF2 gene product
L Sherman, H M Xu, R T Geist, et al.
Genes & Development
|
April 24, 2001
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
H Morrison, L S Sherman, J Legg, et al.
Neurology
|
October 2, 2009
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma
J Yu, H Deshmukh, R J Gutmann, et al.
The Journal of Pathology
|
October 16, 2008
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene
C Filion, T Motoi, A B Olshen, et al.
Neurology
|
November 26, 2003
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1
D H Gutmann, C D James, M Poyhonen, et al.
Somatic Cell and Molecular Genetics
|
May 1, 1993
Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules
P E Gregory, D H Gutmann, A Mitchell, et al.
Journal of Neuropathology and Experimental Neurology
|
November 18, 2000
Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases
A Perry, D X Cai, B W Scheithauer, et al.
Page
of 13